{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:04:19Z","timestamp":1790910259964,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013591","name":"Alliance Healthcare Foundation","doi-asserted-by":"publisher","award":["20130279"],"award-info":[{"award-number":["20130279"]}],"id":[{"id":"10.13039\/100013591","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01-MH-110057"],"award-info":[{"award-number":["R01-MH-110057"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Specialists in Global Health"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002891","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T17:22:25Z","timestamp":1570209745000},"page":"e1002891","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":72,"title":["Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-3301","authenticated-orcid":true,"given":"Sara H.","family":"Browne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Umlauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-890X","authenticated-orcid":true,"given":"Julie","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gonzalez Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-7052","authenticated-orcid":true,"given":"Charles A.","family":"Peloquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Vaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance A.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"pmed.1002891.ref001","unstructured":"Global TB Report WHO. 2018 [cited 2018 August 28]. Available from: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"issue":"2","key":"pmed.1002891.ref002","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/13993003.00543-2016","article-title":"Development, roll-out and impact of Xpert MTB\/RIF for tuberculosis: what lessons have we learnt and how can we do better?","volume":"48","author":"H Albert","year":"2016","journal-title":"Eur Respir J"},{"key":"pmed.1002891.ref003","unstructured":"Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR\/RR-TB). 2018. [cited 2018 Aug]. Available from: [http:\/\/www.who.int\/tb\/publications\/2018\/rapid_communications_MDR\/en\/."},{"issue":"1","key":"pmed.1002891.ref004","doi-asserted-by":"crossref","first-page":"00010","DOI":"10.1183\/23120541.00010-2015","article-title":"New anti-tuberculosis drugs and regimens: 2015 update","volume":"1","author":"L D'Ambrosio","year":"2015","journal-title":"ERJ Open Res"},{"issue":"7","key":"pmed.1002891.ref005","doi-asserted-by":"crossref","first-page":"e1002595","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies","volume":"15","author":"N Alipanah","year":"2018","journal-title":"PLoS Med"},{"issue":"4","key":"pmed.1002891.ref006","doi-asserted-by":"crossref","first-page":"e10043","DOI":"10.1371\/journal.pone.0010043","article-title":"Risk factors associated with default among new smear positive TB patients treated under DOTS in India","volume":"5","author":"S Vijay","year":"2010","journal-title":"PLoS ONE"},{"issue":"1","key":"pmed.1002891.ref007","first-page":"12","article-title":"Status of re-registered patients for tuberculosis treatment under DOTS programme","volume":"54","author":"V Chandrasekaran","year":"2007","journal-title":"Indian J Tuberc"},{"issue":"5","key":"pmed.1002891.ref008","first-page":"556","article-title":"Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India","volume":"9","author":"A Thomas","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"pmed.1002891.ref009","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/ciu186","article-title":"The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study","volume":"58","author":"FM Marx","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pmed.1002891.ref010","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1371\/journal.pmed.0030384","article-title":"Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance","volume":"3","author":"H Cox","year":"2006","journal-title":"PLoS Med"},{"issue":"8","key":"pmed.1002891.ref011","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3201\/eid1308.051327","article-title":"High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa","volume":"13","author":"S den Boon","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"pmed.1002891.ref012","doi-asserted-by":"crossref","first-page":"e1004749","DOI":"10.1371\/journal.pcbi.1004749","article-title":"The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB","volume":"12","author":"D. Cadosch","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"pmed.1002891.ref013","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41591-018-0224-2","article-title":"A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis","volume":"24","author":"MZ Imperial","year":"2018","journal-title":"Nat Med"},{"issue":"10","key":"pmed.1002891.ref014","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1164\/rccm.200605-637OC","article-title":"Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis","volume":"174","author":"K.C. Chang","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"pmed.1002891.ref015","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.2409005","article-title":"In the treatment of tuberculosis, you get what you pay for","volume":"170","author":"A.A. Vernon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"pmed.1002891.ref016","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2334-13-468","article-title":"Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study","volume":"13","author":"R Vashishtha","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pmed.1002891.ref017","doi-asserted-by":"crossref","first-page":"e00108","DOI":"10.1128\/mBio.00108-11","article-title":"Effect of Administration of Moxifloxacin plus Rifampin against Mycobacterium tuberculosis for 7 of 7 Days versus 5 of 7 Days in an In Vitro Pharmacodynamic System","volume":"2","author":"GL Drusano","year":"2011","journal-title":"mBio"},{"issue":"5","key":"pmed.1002891.ref018","doi-asserted-by":"crossref","first-page":"588","DOI":"10.5588\/ijtld.15.0738","article-title":"Enhancing management of tuberculosis treatment with video directly observed therapy in New York City","volume":"20","author":"C Chuck","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"pmed.1002891.ref019","first-page":"976","article-title":"Treatment costs of directly observed therapy and traditional therapy for Mycobacterium tuberculosis: a comparative analysis","volume":"3","author":"SE Weis","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"pmed.1002891.ref020","volume-title":"Community contribution to TB care: practice and policy: review of experience of community contribution to TB care and recommendations to national TB programs","author":"D Maher","year":"2003"},{"issue":"6","key":"pmed.1002891.ref021","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/heapol\/czi047","article-title":"Tuberculosis patient adherence to direct observation: results of a social study in Pakistan","volume":"20","author":"J Walley","year":"2005","journal-title":"Health Policy and Planning"},{"issue":"4","key":"pmed.1002891.ref022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cpt.180","article-title":"Optimizing the clinical pharmacology of tuberculosis medications","volume":"98","author":"EF Egelund","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"pmed.1002891.ref023","first-page":"3","article-title":"Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures","volume":"6","author":"CM Tam","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"pmed.1002891.ref024","first-page":"700","article-title":"Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service\/British Medical Research Council","volume":"143","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"8673","key":"pmed.1002891.ref025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(89)91788-1","article-title":"Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis","volume":"2","author":"A Castelo","year":"1989","journal-title":"Lancet"},{"issue":"7875","key":"pmed.1002891.ref026","first-page":"237","article-title":"Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils","volume":"2","author":"W Fox","year":"1974","journal-title":"Lancet"},{"issue":"1","key":"pmed.1002891.ref027","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1109\/TBME.2014.2341272","article-title":"An ingestible sensor for measuring medication adherence","volume":"62","author":"H Hafezi","year":"2015","journal-title":"IEEE Trans Biomed Eng"},{"issue":"7","key":"pmed.1002891.ref028","first-page":"e277","article-title":"Early clinical experience with networked system for promoting patient self-management","volume":"17","author":"K.Y. Au-Yeung","year":"2011","journal-title":"Am J Manag Care"},{"issue":"4","key":"pmed.1002891.ref029","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.2196\/mhealth.4292","article-title":"Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform","volume":"3","author":"SH Browne","year":"2015","journal-title":"JMIR Mhealth Uhealth"},{"issue":"5","key":"pmed.1002891.ref030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1109\/MPUL.2012.2205777","article-title":"A digital health solution for using and managing medications: wirelessly observed therapy","volume":"3","author":"L DiCarlo","year":"2012","journal-title":"IEEE Pulse"},{"issue":"3","key":"pmed.1002891.ref031","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/TP.0b013e31829b7571","article-title":"Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants","volume":"96","author":"U Eisenberger","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"pmed.1002891.ref032","doi-asserted-by":"crossref","first-page":"e53373","DOI":"10.1371\/journal.pone.0053373","article-title":"Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy","volume":"8","author":"R Belknap","year":"2013","journal-title":"PLoS ONE"},{"issue":"5152","key":"pmed.1002891.ref033","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and Opioid-Involved Overdose Deaths\u2014United States, 2013\u20132017","volume":"67","author":"L Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"pmed.1002891.ref034","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/cpt.760","article-title":"Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co-encapsulation","volume":"103","author":"SH Browne","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"pmed.1002891.ref035","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2147\/NDT.S116029","article-title":"Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole","author":"T Peters-Strickland","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9","key":"pmed.1002891.ref036","doi-asserted-by":"crossref","first-page":"e45724","DOI":"10.1371\/journal.pone.0045724","article-title":"The rate of sputum smear-positive tuberculosis after treatment default in a high-burden setting: a retrospective cohort study","volume":"7","author":"FM Marx","year":"2012","journal-title":"PLoS ONE"},{"key":"pmed.1002891.ref037","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511802843","volume-title":"Bootstrap Methods and Their Application","author":"AC Davison","year":"1997"},{"key":"pmed.1002891.ref038","unstructured":"FDA. FDA approves pill with sensor that digitally tracks if patients have ingested their medication [Internet]. [cited 2017 Nov 13]. Available from: https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm584933.htm."},{"issue":"7","key":"pmed.1002891.ref039","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 YearsChanging Face of Heroin Use in the United StatesChanging Face of Heroin Use in the United States","volume":"71","author":"TJ Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"pmed.1002891.ref040","doi-asserted-by":"crossref","unstructured":"Abstracts of the Society of General Internal Medicine 33rd Annual Meeting. Minneapolis, Minnesota, USA. April 28\u2013May 1, 2010. J Gen Intern Med. 2010;25 Suppl. 3:S205\u2013567.","DOI":"10.1007\/s11606-010-1338-5"},{"key":"pmed.1002891.ref041","volume-title":"Effective Patient Education: A Guide to Increased Adherence","author":"DR Falvo","year":"2011"},{"key":"pmed.1002891.ref042","unstructured":"Welfare IDoHa. Case Management. In: Welfare IDoHa, editor. 2007."}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T01:10:21Z","timestamp":1664586621000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002891"}},"subtitle":[],"editor":[{"given":"Mark","family":"Hatherill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002891","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]}}}